Skip to main content
. 2015 Jul 14;26(4):284–292. doi: 10.3802/jgo.2015.26.4.284

Table 3. Five-year DFS and OS according to the recourse to lymphadenectomy and adjuvant therapies.

Adiuvant therapy No lymphadenectomy (n=89) Pelvic+/-aortic lymphadenectomy (n=165)
5-Year DFS 5-Year OS 5-Year DFS 5-Year OS
None 62.39 79.17 64.41 76.61
EBRT 70.73 75.61 67.56 79.35
Chemotherapy 63.56 70.23 65.86 75.46
Sequential chemo- EBRT 100 100 79.56 86.09

DFS, disease-free survival; EBRT, external beam radiotherapy; OS, overall survival.